Global Tissue Sealants Market This market research provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Research classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
The upsurge in the number of surgical procedures especially orthopedic surgeries due to the sports injuries and accidents and cardiac surgeries owing to a high prevalence of cardiovascular diseases are boosting the growth of the tissue sealants market globally. As per the OECD stats, in Canada, the number of surgeries performed was 378,448 during 2013 and it increased to 396,218 in 2017. In France, surgeries performed in 2014 were 773,308 and it raised to 863,837 by 2017.
Similarly, other European countries, such as Spain, Italy, the Netherlands, etc., have also witnessed a rise in the number of surgeries performed. Furthermore, growing awareness about the tissue sealants, benefits, and applications of tissue sealants, an increase in R&D investments in developing novel tissue sealants are also propelling the growth of the global tissue sealants market. They offer advantages, such as minimal blood loss, better closure, and easy and less painful operation without the need for removal. However, stringent regulatory scenario and high cost of the products act as major restraints of the tissue sealants market.
Avail a Sample Copy before Purchase:
Market competition by Top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the Top players including-
Avin Darou, Adhesys Medical GmbH, Becton, Dickinson and Company, C.R. Bard, Inc., Cohera Medical, CryoLife, CSL Behring, Ethicon US, LLC, Integra LifeSciences Corporation, Tissuemed Ltd
Fibrin sealant dominates the Global Tissue Sealants Market
Fibrin sealants reconstruct the final phase of the blood coagulation cascade through the reaction of thrombin and fibrinogen at the wound spot to produce a cross-linked fibrin clot that stops bleeding. These products are generally indicated as an adjunct to hemostasis when control of bleeding by standard surgical techniques is ineffective or impractical. In orthopedic procedures, elective or urgent, bleeding is to be seriously considered, since usually both bones and soft tissues are injured or cut, so adapted haemostatic means have to be used. Fibrin sealants are known to decrease bleeding in total knee arthroplasty (TKA) compared with standard methods of hemostasis and can be used to establish hemostasis in a TKA lesion Some of the FDA-licensed Fibrin sealants are TISSEEL and ARTISS (Baxter Healthcare Corp.), EVICEL (Omrix Biopharmaceuticals, Ltd., a Johnson & Johnson company), and RAPLIXA (ProFibrix, BV. [The Medicines Company]). Advantages associated with the application of fibrin sealants are improved patient outcomes, negligible complications, and declined chances of mortality are attributed to propel the growth of the fibrin Sealants segment during the forecast period.
North America Dominates the Global Tissue Sealants Market
North America holds a leading position in the Tissue Sealants market during the forecast period owing to the increase in per capita health expenditures, the advancement in the healthcare infrastructure, increase in the number of bone injuries and sports injuries, and rise in number of hip and knee replacement surgeries in the United States have led to a swift growth of the global tissue sealants market. Over the time, Asia Pacific is expected to witness profitable progress due to the presence of untapped medical needs of the patient population of this region, and swiftly improving healthcare infrastructure in the emerging economies of India and China.
Market segment by Regions/Countries, this report covers
North America (U.S., Canada, Mexico)
Global (Germany, UK, France, Rest of Global)
Asia Pacific (China, India, Japan, Rest of Asia Pacific)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East & Africa
Get Exclusive Discount at-
Major points covered in this research are:-
─Tissue Sealants Market Overview, Segment by Type (Product Category), by Application, by Region (2020-2025), Competition by Manufacturers
─Global Market Size (Value) of Tissue Sealants (2020-2025)
─Global Tissue Sealants Capacity, Production, Revenue (Value), Supply (Production), Consumption, Export, Import by Region (2020-2025)
─Global Tissue Sealants Production, Revenue (Value), Price Trend by Type
─Global Tissue Sealants Market Analysis by Application
─Global Tissue Sealants Manufacturers Profiles/Analysis
─Tissue Sealants Manufacturing Cost Analysis
─Industrial Chain, Sourcing Strategy and Downstream Buyers
─Marketing Strategy Analysis, Distributors/Traders
─Market Effect Factors Analysis
─Global Tissue Sealants Market Forecast (2020-2025)
─Research Findings and Conclusion
Finally, this Tissue Sealants report covers the market scenario and its development prospects over the coming years. Report likewise manages the type analysis, contrasting it with the significant application, recent Tissue Sealants product development and gives an outline of the potential Global market.
Irfan Tamboli (Sales)
Phone: + 1704 266 3234